HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...

The anti-CD40 antibody tegoprubart offers a tacrolimus-free immunosuppression option for preventing islet transplant ...

During a live event, Hannah Choe, MD, analyzed key findings from the AGAVE-201 trial of axatilimab in chronic graft-vs-host disease. A significant number of patients who develop chronic graft-vs-host ...

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole while a clear bag slowly empties into a vein. A new generation of ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...

A new business aiming to provide tailored and monitored holistic therapy to optimize overall health and wellness recently opened in uptown Centerville. Eazy IV Hydration and Wellness Clinic at 62 East ...

In recent years, continuous intraperitoneal insulin infusion (CIPII) has become a valid therapeutic option to achieve good glycemic control for patients with unstable type 1 diabetes and subcutaneous ...

In 12 subjects with normal glucose tolerance fructose infusion was associated with a rise in plasma insulin and plasma corticoid levels. Similar but lesser changes were seen in seven maturity onset ...

Kirsty 100units/mL is supplied as a 3mL single-patient-use prefilled pen as well as a 10mL multiple-dose vial. The approval of insulin aspart-xjhz was supported by a comprehensive data package that ...

Credit: Getty Images Researchers conducted a retrospective analysis to assess hypoglycemia rates among patients receiving IV insulin through a dynamic dosing algorithm. Glucopilot dynamic dosing ...